CURV Earnings

CURV reported its FY2026Q3 earnings on 2025-12-03, showcasing a revenue of 235.15M against an estimate of 239.90M, resulting in a -1.98% surprise. The EPS was -0.06, surpassing the expected -0.01 by -500%. The stock experienced a -13.74% price change on the earnings day and a -14.5% change over the next five days, reflecting market reactions to the results.

Following CURV's FY2026Q3 earnings announcement on 2025-12-03, the stock price moved by -13.74% on the day of the release. Over the subsequent five days, it saw a -14.5% change. Historically, CURV's stock price tends to shift by an average of -3.84% in the 10 days leading up to earnings and -9.47% in the 10 days following, providing insight into potential market.

For 2027/Q1, analysts estimate CURV's annual revenue to reach 234.14M, while the EPS is projected at 0.06. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between CURV's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2026 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, CURV's stock price typically moves by -3.84% in the 10 days before its earnings and -9.47% in the 10 days after. For the upcoming 2027/Q1 earnings, analysts expect an EPS of 0.06 and revenue of 234.14M.

The earnings call summary indicates a decline in revenue and gross margin, with net income also decreasing. Despite improved operating cash flow, the overall financial performance is weak. The absence of positive strategic initiatives or shareholder return plans, coupled with the lack of clear guidance in the Q&A, suggests a negative sentiment. The risks associated with forward-looking statements further contribute to uncertainty, likely leading to a negative stock price reaction over the next two weeks.